All that 'PM wonderfulness' in the paper, yet Avatar and Excellence yield disappointing results. Not a good look. Missling. We're not hearing anything about Rett since the Excellence disappointment, and it's not surprising. It's likely on the back burner. Hopefully FX is starting soon; it's been 3 years now. Same with PD and the "undisclosed indication".
Market Data 
Markets 
AI
